Evidence map›Paper›PMID 40050115›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2025

Hippocampal Neural Stem Cell Exosomes Promote Brain Resilience against the Impact of Tau Oligomers.

Balaji Krishnan, Michela Marcatti, Anna Fracassi, Wen-Ru Zhang, Jutatip Guptarak, Kathia Johnson, Auston Grant, Rakez Kayed, Giulio Taglialatela, Maria-Adelaide Micci

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Balaji KrishnanMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.ORCID https://orcid.org/0000-0003-2074-4165
Michela MarcattiMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.
Anna FracassiMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.
Wen-Ru ZhangMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.
Jutatip GuptarakMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.
Kathia JohnsonDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, Texas 77555.
Auston GrantDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, Texas 77555.
Rakez KayedMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555.
Giulio TaglialatelaMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555 mmicci@utmb.edu gtaglial@utmb.edu.
Maria-Adelaide MicciDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, Texas 77555 mmicci@utmb.edu gtaglial@utmb.edu.ORCID https://orcid.org/0000-0001-6689-2994

Funding

Mechanisms of resistance to cognitive decline in ADR01AG042890 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TAGLIALATELA, GIULIO · 2013 to 2017
$1.5M
NIA NIH HHS R01 AG042890
6 · The paper itself

Abstract

A promising therapeutic intervention for preventing the onset and progression of Alzheimer's disease is to protect and improve synaptic resilience, a well-established early vulnerability associated with the toxic effects of oligomers of amyloid β (AβO) and Tau (TauO). We have previously reported that exosomes from hippocampal neural stem cells (NSCs) protect synapses against AβO. Here, we demonstrate how exosomes can also shield against TauO toxicity in adult mice synapses, potentially benefiting primary and secondary tauopathies. Exosomes from hippocampal NSCs (NSCexo) or mature neurons (MNexo) were delivered intracerebroventricularly to adult wild-type male mice (C57Bl6/J). After 24 h, TauO were administered to suppress long-term potentiation (LTP) and memory, measured by electrophysiology and contextual memory deficits measured using novel object recognition test. We also assessed TauO binding to synapses using isolated synaptosomes and cultured hippocampal neurons. Furthermore, mimics of select miRNAs present in NSCexo were delivered intracerebroventricularly to mice prior to assessment of TauO-induced suppression of hippocampal LTP. Our results showed that NSC-, not MN-, derived exosomes, prevented TauO-induced memory impairment, LTP suppression, and reduced Tau accumulation and TauO internalization in synaptosomes. These findings suggest that NSC-derived exosomes can protect against synaptic dysfunction and memory deficits induced by both AβO and TauO, offering a novel therapeutic strategy for multiple neurodegenerative states.

Indexed as

ExosomesHippocampusNeural Stem Cellstau ProteinsAnimalsCells, CulturedLong-Term PotentiationMaleMiceMice, Inbred C57BLtau ProteinsAlzheimer's diseaseexosomesmiRNAsneural stem cellssynapsesTau oligomers

Identifiers

PMID40050115
PMCPMC12005371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.